Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹8,869 Cr₹9,151 Cr₹8,171 Cr₹7,082 Cr₹6,559 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹8,869 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹8,869 Cr
Mar2025₹9,151 Cr
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2026 ₹8,869 Cr
-3.08
Mar2025 ₹9,151 Cr
11.99
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,311.1 Cr 3.9% 5% -12.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,593.0 Cr 2% 6.7% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,737.0 Cr 3.5% 2.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,290.0 Cr 4.6% 9.9% 41.5% Stock Analytics
CIPLA ₹117,327.0 Cr -0.3% 3.7% -2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,994.0 Cr 1.1% 5.9% 6.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.9%

5%

-12.5%

SENSEX

2.2%

5.1%

-7%


You may also like the below Video Courses